![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Resistance Analyses of Bictegravir/Emtricitabine/Tenofovir Alafenamide Switch Studies
|
|
|
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Kristen Andreatta, Madeleine Willkom, Ross Martin, Silvia Chang, Hal Martin, Hiba Graham, Erin Quirk, and Kirsten L. White
Gilead Sciences, Inc., Foster City, CA
![0326181](../images%20/032618/032618-7/0326181.gif)
![0326182](../images%20/032618/032618-7/0326182.gif)
![0326183](../images%20/032618/032618-7/0326183.gif)
![0326184](../images%20/032618/032618-7/0326184.gif)
![0326185](../images%20/032618/032618-7/0326185.gif)
![0326186](../images%20/032618/032618-7/0326186.gif)
![0326187](../images%20/032618/032618-7/0326187.gif)
![0326188](../images%20/032618/032618-7/0326188.gif)
![0326189](../images%20/032618/032618-7/0326189.gif)
![03261810](../images%20/032618/032618-7/03261810.gif)
![03261811](../images%20/032618/032618-7/03261811.gif)
![03261812](../images%20/032618/032618-7/03261812.gif)
![03261813](../images%20/032618/032618-7/03261813.gif)
![03261814](../images%20/032618/032618-7/03261814.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|